Development of Argatroban as an Anticoagulant and Antithrombin Agent in Japan

Publisher： Karger

E-ISSN： 1424-8840|32|3|23-28

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.32, Iss.3, 2003-06, pp. : 23-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Practical Issues in the Development of Argatroban: A Perspective

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 3, 2003-06 ,pp. : 56-65

Karger

Access to resources Recommend Favorite

Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: The SAMURAI‐NVAF Study

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 6, 2015-08 ,pp. : 836-842

John Wiley & Sons Inc

Access to resources Recommend Favorite

Argatroban in Thrombotic Stroke

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 3, 2003-06 ,pp. : 39-45

Karger

Access to resources Recommend Favorite

Bartonella henselae: Association with the Development of Transient Lupus Anticoagulant and Asymptomatic Prolongation of Activated Partial Thromboplastin Time

By Economou Marina   Lithoxopoulou Maria   Aivazis Victor   Tsakalidis Christos   Athanassiou-metaxa Miranda  

Scandinavian Journal of Infectious Diseases, Vol. 35, Iss. 2, 2003-01 ,pp. : 149-149

Informa Healthcare

Access to resources Recommend Favorite

Recommendations for the development of new anticoagulant drugs for pediatric use: communication from the SSC of the ISTH

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 3, 2015-03 ,pp. : 481-484

John Wiley & Sons Inc

Access to resources Recommend Favorite